Summary
Research published in Advanced Materials (2024) demonstrated that chemically fixed MSC spheroids retain their immunomodulatory properties while becoming stable, off-the-shelf therapeutics. 3D Petri Dish® enabled scale-up production of thousands of standardized spheroids.
Fixed MSC Spheroids for Immunomodulation Therapy
Research Overview
Mesenchymal stem cells (MSCs) have powerful immunomodulatory properties but are difficult to store and transport. This breakthrough shows that fixed (preserved) MSC spheroids retain therapeutic activity as shelf-stable products.
How 3D Petri Dish® Enabled This Research
Key Discoveries
- Fixed MSC spheroids retain immunomodulatory activity
- Preservation enables off-the-shelf therapeutic products
- Shape can be engineered for specific applications
- Scalable manufacturing demonstrated
3D Petri Dish® Application
Enabled scale-up preparation of thousands of standardized MSC spheroids for fixation and testing
- Scale-Up Production: Thousands of uniform spheroids per batch
- Size Control: Consistent spheroid size critical for dosing
- Gentle Handling: Preserved spheroid integrity during processing
Frequently Asked Questions
Can fixed cells retain therapeutic activity?
Yes, this research demonstrates that properly fixed MSC spheroids maintain their immunomodulatory properties while becoming stable, storable products.
What are the advantages of MSC spheroids over monolayer MSCs?
MSC spheroids have enhanced immunomodulatory activity, better survival after transplantation, and can be easily handled and dosed compared to dissociated cells.
How many MSC spheroids can be produced with 3D Petri Dish?
The 12-256 kit produces 256 spheroids per well (3,072 per 12-well plate), enabling rapid scale-up for therapeutic applications.